-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Initiates Coverage On Helus Pharma with Overweight Rating, Announces Price Target of $16

Benzinga·07/27/2026 12:52:42
Listen to the news
Wells Fargo analyst Benjamin Burnett initiates coverage on Helus Pharma (NASDAQ:HELP) with a Overweight rating and announces Price Target of $16.